Terumo Corporation

Symbol: TRUMF

PNK

37.754

USD

Market price today

  • 19.1953

    P/E Ratio

  • -0.0049

    PEG Ratio

  • 28.12B

    MRK Cap

  • 0.00%

    DIV Yield

Terumo Corporation (TRUMF) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.51%

Operating Profit Margin

0.15%

Net Profit Margin

0.11%

Return on Assets

0.06%

Return on Equity

0.08%

Return on Capital Employed

0.10%

Company general description and statistics

Sector: Healthcare
Industry: Medical Instruments & Supplies
CEO:Mr. Shinjiro Sato
Full-time employees:30207
City:Tokyo
Address:2-44-1, Hatagaya
IPO:2011-04-13
CIK:

Terumo Corporation engages in the manufacture and sale of medical products and equipment worldwide. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.

General Outlook

When we look at how much money they make before expenses, they keep 0.513% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.146%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.112%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.059% return, is a testament to Terumo Corporation's adeptness in optimizing resource deployment. Terumo Corporation's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.083%. Furthermore, the proficiency of Terumo Corporation in capital utilization is underscored by a remarkable 0.096% return on capital employed.

Stock Prices

Terumo Corporation's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $16.63, while its low point bottomed out at $16.63. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Terumo Corporation's stock market.

Liquidity Ratios

Analyzing TRUMF liquidity ratios reveals its financial health of the firm. The current ratio of 190.47% gauges short-term asset coverage for liabilities. The quick ratio (103.41%) assesses immediate liquidity, while the cash ratio (46.59%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio190.47%
Quick Ratio103.41%
Cash Ratio46.59%

Profitability Ratios

TRUMF profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 14.66% underscores its earnings before tax deductions. The effective tax rate stands at 23.68%, revealing its tax efficiency. The net income per EBT, 76.32%, and the EBT per EBIT, 100.34%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 14.61%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin14.66%
Effective Tax Rate23.68%
Net Income per EBT76.32%
EBT per EBIT100.34%
EBIT per Revenue14.61%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.90, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding103
Days of Inventory Outstanding231
Operating Cycle305.59
Days of Payables Outstanding74
Cash Conversion Cycle232
Receivables Turnover4.87
Payables Turnover4.94
Inventory Turnover1.58
Fixed Asset Turnover2.27
Asset Turnover0.52

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 179.95, and free cash flow per share, 81.31, depict cash generation on a per-share basis. The cash per share value, 243.81, showcases liquidity position. A payout ratio of 0.32 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.15, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share179.95
Free Cash Flow per Share81.31
Cash per Share243.81
Payout Ratio0.32
Operating Cash Flow Sales Ratio0.15
Free Cash Flow to Operating Cash Flow Ratio0.45
Cash Flow Coverage Ratio0.59
Short Term Coverage Ratio0.89
Capital Expenditure Coverage Ratio1.82
Dividend Paid and Capex Coverage Ratio1.27
Dividend Payout Ratio0.02

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 13.37%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.19, we discern the balance between debt and equity financing. The long-term debt to capitalization, 5.81%, and total debt to capitalization, 15.69%, ratios shed light on its capital structure. An interest coverage of 45.48 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio13.37%
Debt Equity Ratio0.19
Long Term Debt to Capitalization5.81%
Total Debt to Capitalization15.69%
Interest Coverage45.48
Cash Flow to Debt Ratio0.59
Company Equity Multiplier1.39

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 1092.72, provides a glimpse into top-line earnings distributed across each share. Net income per share, 119.00, reflects the portion of profit attributed to each share. The book value per share, 1480.20, represents the net asset value distributed per share, while the tangible book value per share, 763.18, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share1092.72
Net Income Per Share119.00
Book Value Per Share1480.20
Tangible Book Value Per Share763.18
Shareholders Equity Per Share1480.20
Interest Debt Per Share314.35
Capex Per Share-96.15

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 14.57%, indicates top-line expansion, while the gross profit growth, 13.08%, reveals profitability trends. EBIT growth, 17.86%, and operating income growth, 17.86%, offer insights into operational profitability progression. The net income growth, 0.58%, showcases bottom-line expansion, and the EPS growth, 14.78%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth14.57%
Gross Profit Growth13.08%
EBIT Growth17.86%
Operating Income Growth17.86%
Net Income Growth0.58%
EPS Growth14.78%
EPS Diluted Growth14.95%
Weighted Average Shares Growth0.15%
Weighted Average Shares Diluted Growth-0.01%
Dividends per Share Growth10.71%
Operating Cash Flow Growth16.45%
Free Cash Flow Growth75.60%
10-Year Revenue Growth per Share75.59%
5-Year Revenue Growth per Share11.50%
3-Year Revenue Growth per Share13.42%
10-Year Operating CF Growth per Share182.64%
5-Year Operating CF Growth per Share15.07%
3-Year Operating CF Growth per Share46.17%
10-Year Net Income Growth per Share90.83%
5-Year Net Income Growth per Share-8.83%
3-Year Net Income Growth per Share1.35%
10-Year Shareholders Equity Growth per Share132.37%
5-Year Shareholders Equity Growth per Share71.41%
3-Year Shareholders Equity Growth per Share40.21%
10-Year Dividend per Share Growth per Share181.99%
5-Year Dividend per Share Growth per Share37.99%
3-Year Dividend per Share Growth per Share15.96%
Receivables Growth5.80%
Inventory Growth13.08%
Asset Growth9.07%
Book Value per Share Growth18.00%
Debt Growth-13.27%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 1,404,378,440,911.365, captures the company's total value, considering both debt and equity. Income quality, 1.01, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.37, gauges operational efficiency, while the research and development to revenue, 7.51%, highlights investment in innovation. The ratio of intangibles to total assets, 33.59%, indicates the value of non-physical assets, and capex to operating cash flow, -61.41%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value1,404,378,440,911.365
Income Quality1.01
Sales General and Administrative to Revenue0.37
Research and Development to Revenue7.51%
Intangibles to Total Assets33.59%
Capex to Operating Cash Flow-61.41%
Capex to Revenue-8.80%
Capex to Depreciation-102.75%
Graham Number1990.81
Return on Tangible Assets8.40%
Graham Net Net-84.94
Working Capital393,395,000,000
Tangible Asset Value572,853,000,000
Net Current Asset Value120,234,000,000
Average Receivables145,165,500,000
Average Payables89,640,500,000
Average Inventory224,077,000,000
Days Sales Outstanding68
Days Payables Outstanding89
Days of Inventory On Hand226
ROIC6.72%
ROE0.08%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.56, and the price to book ratio, 1.56, reflect the market's valuation relative to the company's book value. The price to sales ratio, 4.28, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 62.58, and price to operating cash flows, 14.20, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio1.56
Price to Book Ratio1.56
Price to Sales Ratio4.28
Price Cash Flow Ratio14.20
Enterprise Value Multiple18.02
Price Fair Value1.56
Price to Operating Cash Flow Ratio14.20
Price to Free Cash Flows Ratio62.58
Price to Tangible Book Ratio1.22
Enterprise Value to Sales1.71
Enterprise Value Over EBITDA7.38
EV to Operating Cash Flow11.95
Earnings Yield6.57%
Free Cash Flow Yield3.34%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Terumo Corporation (TRUMF) on the PNK in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 19.195 in 2024.

What is the ticker symbol of Terumo Corporation stock?

The ticker symbol of Terumo Corporation stock is TRUMF.

What is company IPO date?

IPO date of Terumo Corporation is 2011-04-13.

What is company current share price?

Current share price is 37.754 USD.

What is stock market cap today?

The market cap of stock today is 28115540847.000.

What is PEG ratio in 2024?

The current -0.005 is -0.005 in 2024.

What is the number of employees in 2024?

In 2024 the company has 30207.